Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Therapeutic Advances in Medical Oncology|June 4, 2020
Secondary glioblastoma metastasis outside the central nervous system in a young HIV-infected patientLeonardo Fonseca Rodrigues, Aline Helen da Silva Camacho, Tania Cristina Leite de Sampaio E SpohrEndocrine|July 5, 2020
Cyclin A in nonfunctioning pituitary adenomasElisa B Lamback, Alexandro Guterres, Monique Alvares Barbosa, et al.Endocrine|April 2, 2025
TTF1-positive posterior pituitary tumors: a single-center experience of 10 yearsElisa Lamback, Aline Helen da Silva Camacho, Anna Clara Castro Araujo, et al.International Journal of Molecular Sciences|February 11, 2023
miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in AcromegalyDaniel G Henriques, Renan Lyra Miranda, Rômulo Sperduto Dezonne, et al.Pituitary|September 6, 2022
Characterization of sporadic somatotropinomas with high GIP receptor expressionOlivia Faria, Renan Lyra Miranda, Carlos Henrique de Azeredo Lima, et al.Endocrine|October 22, 2020
Telomerase expression in clinically non-functioning pituitary adenomasLiana Lumi Ogino, Elisa Baranski Lamback, Alexandro Guterres, et al.Journal of Cellular and Molecular Medicine|January 30, 2018
Molecular evidence and clinical importance of β-arrestins expression in patients with acromegalyMaria Caroline Alves Coelho, Marina Lipkin Vasquez, Luiz Eduardo Wildemberg, et al.Scientific Reports|February 6, 2019
Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profilesMaria Caroline Alves Coelho, Marina Lipkin Vasquez, Luiz Eduardo Wildemberg, et al.The Journal of Clinical Endocrinology and Metabolism|March 9, 2021
Machine Learning-based Prediction Model for Treatment of Acromegaly With First-generation Somatostatin Receptor LigandsLuiz Eduardo Wildemberg, Aline Helen da Silva Camacho, Renan Lyra Miranda, et al.Pageof 1